Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Alovudine
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Other names | Fluorothymidine |
ATC code |
|
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H13FN2O4 |
Molar mass | 244.222 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Alovudine (fluorothymidine) is an antiviral agent which was being developed by Medivir. It was discontinued after a Phase II trial in 2005 due to toxicity. It is a DNA polymerase inhibitor.
See also
- Fluorothymidine F-18, an isotopically enriched version of alovudine used as a PET tracer
Baltimore I |
|
||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hepatitis B (VII) | |||||||||||||||||||||
Multiple/general |
|
||||||||||||||||||||
|
Hepatitis C |
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Hepatitis D | |||||||||
Picornavirus | |||||||||
Anti-influenza agents | |||||||||
Multiple/general |
|
||||||||
|